Table of Contents Author Guidelines Submit a Manuscript
International Journal of Microbiology
Volume 2012, Article ID 391251, 4 pages
http://dx.doi.org/10.1155/2012/391251
Research Article

Comparison of Disk Diffusion and Etest Methods to Determine the Susceptibility of Staphylococcus aureus Circulating in Riyadh, Saudi Arabia to Fusidic Acid

1Department of Pathology, Microbiology Unit, College of Medicine, King Saud University and King Khalid University Hospital, Riyadh 11411, Saudi Arabia
2Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT 06510, USA
3Pathology and Laboratory Medicine Service, Veteran Affairs (VA) Connecticut Healthcare System, West Haven, CT 06516, USA
4Departments of Pediatrics and Pharmacology, Yale School of Medicine, New Haven, CT 06510, USA
5Department of Medical Sciences, The Frank H. Netter MD School of Medicine, Quinnipiac University, Hamden, CT 06518-7908, USA

Received 12 March 2012; Revised 24 May 2012; Accepted 7 June 2012

Academic Editor: John Tagg

Copyright © 2012 Ali M. Somily et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. O. Godtfredsen, S. Jahnsen, H. Lorck, K. Roholt, and L. Tybring, “Fusidic acid: a new antibiotic,” Nature, vol. 193, no. 4819, p. 987, 1962. View at Publisher · View at Google Scholar · View at Scopus
  2. B. P. Howden and M. L. Grayson, “Dumb and dumber—the potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureus,” Clinical Infectious Diseases, vol. 42, no. 3, pp. 394–400, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. J. D. Anderson, “Fusidic acid: new opportunities with an old antibiotic,” Canadian Medical Association Journal, vol. 122, no. 7, pp. 765–769, 1980. View at Google Scholar · View at Scopus
  4. P. Collignon and J. Turnidge, “Fusidic acid in vitro activity,” International Journal of Antimicrobial Agents, vol. 12, no. 2, pp. S45–S58, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. E. M. Brown and R. Wise, “Fusidic acid cream for impetigo. Fusidic acid should be used with restraint,” British Medical Journal, vol. 324, no. 7350, p. 1394, 2002. View at Google Scholar · View at Scopus
  6. E. M. Brown and P. Thomas, “Fusidic acid resistance in Staphylococcus aureus isolates,” Lancet, vol. 359, no. 9308, p. 803, 2002. View at Google Scholar · View at Scopus
  7. V. C. Weston, T. C. Boswell, R. G. Finch, and W. Perkins, “Fusidic acid cream for impetigo. Emergence of resistance to fusidic acid limits its use,” British Medical Journal, vol. 324, no. 7350, p. 1395, 2002. View at Google Scholar · View at Scopus
  8. J. Turnidge and P. Collignon, “Resistance to fusidic acid,” International Journal of Antimicrobial Agents, vol. 12, no. 2, supplement, pp. S35–S44, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. F. G. O'Brien, C. Price, W. B. Grubb, and J. E. Gustafson, “Genetic characterization of the fusidic acid and cadmium resistance determinants of Staphylococcus aureus plasmid pUB101,” Journal of Antimicrobial Chemotherapy, vol. 50, no. 3, pp. 313–321, 2002. View at Google Scholar · View at Scopus
  10. R. Skov, N. Frimodt-Møller, and F. Espersen, “Correlation of MIC methods and tentative interpretive criteria for disk diffusion susceptibility testing using NCCLS methodology for fusidic acid,” Diagnostic Microbiology and Infectious Disease, vol. 40, no. 3, pp. 111–116, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. F. B. McLaws, A. R. Larsen, R. L. Skov, I. Chopra, and A. J. O'Neill, “Distribution of fusidic acid resistance determinants in methicillin-resistant Staphylococcus aureus,” Antimicrobial Agents and Chemotherapy, vol. 55, no. 3, pp. 1173–1176, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. EUCAST, “Breakpoint tables for interpretation of MIC and zone diameters. The European Committee on Antimicrobial Susceptibility Testing,” 2009.
  13. R. N. Jones, R. E. Mendes, H. S. Sader, and M. Castanheira, “In vitro antimicrobial findings for fusidic acid tested against contemporary (2008-2009) gram-positive organisms collected in the United States,” Clinical Infectious Diseases, vol. 52, no. 7, pp. S477–S486, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. M. M. Baddour, M. M. Abuelkheir, and A. J. Fatani, “Trends in antibiotic susceptibility patterns and epidemiology of MRSA isolates from several hospitals in Riyadh, Saudi Arabia,” Annals of Clinical Microbiology and Antimicrobials, vol. 5, article 30, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. CLSI, “Performance standards for antimicrobial susceptibility testing; Twenty-first informational supplement M 100-S21 Vol.31 No.1,” 2011.
  16. E. Toma and D. Barriault, “Antimicrobial activity of fusidic acid and disk diffusion susceptibility testing criteria for gram-positive cocci,” Journal of Clinical Microbiology, vol. 33, no. 7, pp. 1712–1715, 1995. View at Google Scholar · View at Scopus